DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

Abbott Laboratories (NYSE: ABT)

46.02 0.38 (0.83%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ABT $46.02 0.83%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $45.61
Previous Close $45.64
Daily Range $45.21 - $46.11
52-Week Range $39.28 - $51.74
Market Cap $68.6B
P/E Ratio 28.89
Dividend (Yield) $0.96 (2.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 9,191,386
Average Daily Volume 6,505,316
Current FY EPS $2.16




Drug Makers

Abbott Laboratories (ABT) Description

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Website:

News & Commentary

Better Dividend Stock: AbbVie or Johnson & Johnson?

AbbVie and Johnson & Johnson are widely recognized as top-tier dividend stocks. Here is a look at which one offers the better long-term prospects for income-seeking investors.

Premarket Biotech Digest: Geron EDP Today, Repatha Approval, Mylan Perrigo Deal

The 10 Most Recession-Proof Dividend Aristocrats

Benzinga's M&A Chatter for Thursday August 27, 2015

Edwards Completes CardiAQ Buyout, Resolves FORTIS Issue

Stocks Rally to Erase Week's Losses

Cramer Remains Cautious on Stocks

Benzinga's Volume Movers

Medtronic Bets Nearly Half A Billion Dollars On Transcatheter Mitral Valve Market

U.S. Stocks Seek to Continue Recovery

Will Medtronic's Twelve Buy Expedite Growth in Mitral Valves?

See More ABT News...

ABT's Top Competitors

ABT $46.02 (0.83%)
Current stock: ABT
JNJ $95.17 (-1.09%)
Current stock: JNJ
NVS $98.35 (-0.29%)
Current stock: NVS
RHHBY $34.16 (-1.98%)
Current stock: RHHBY